These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
44 related items for PubMed ID: 2996822
1. [T2-analysis of normal and pathological structures of the head]. Skalej M, Higer HP, Meves M, Brückner A, Bielke G, Meindl S, Rinck PA, Pfannenstiel P. Digitale Bilddiagn; 1985 Sep; 5(3):112-9. PubMed ID: 2996822 [Abstract] [Full Text] [Related]
8. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology. Magalhaes A, Godfrey W, Shen Y, Hu J, Smith W. Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725 [Abstract] [Full Text] [Related]
9. [NMR-tomography of cerebral midline tumors and cervical cord processes in children]. Just M, Higer P, Gutjahr P, Pfannenstiel P. Rofo; 1986 Aug; 145(2):163-6. PubMed ID: 3018853 [Abstract] [Full Text] [Related]
10. Tissue characterization of glioma by proton magnetic resonance spectroscopy and perfusion-weighted magnetic resonance imaging: glioma grading and histological correlation. Toyooka M, Kimura H, Uematsu H, Kawamura Y, Takeuchi H, Itoh H. Clin Imaging; 2008 Aug; 32(4):251-8. PubMed ID: 18603178 [Abstract] [Full Text] [Related]
11. Association of 99mTc-MIBI brain SPECT and proton magnetic resonance spectroscopy (1H-MRS) to assess glioma recurrence after radiotherapy. Palumbo B, Lupattelli M, Pelliccioli GP, Chiarini P, Moschini TO, Palumbo I, Siepi D, Buoncristiani P, Nardi M, Giovenali P, Palumbo R. Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):88-93. PubMed ID: 16557208 [Abstract] [Full Text] [Related]
12. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas. Law M, Oh S, Johnson G, Babb JS, Zagzag D, Golfinos J, Kelly PJ. Neurosurgery; 2006 Jun; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889 [Abstract] [Full Text] [Related]
13. Intra-operative characterization of gliomas by near-infrared spectroscopy: possible association with prognosis. Asgari S, Röhrborn HJ, Engelhorn T, Stolke D. Acta Neurochir (Wien); 2003 Jun; 145(6):453-59; discussion 459-60. PubMed ID: 12836069 [Abstract] [Full Text] [Related]
14. 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI. Pirzkall A, Li X, Oh J, Chang S, Berger MS, Larson DA, Verhey LJ, Dillon WP, Nelson SJ. Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):126-37. PubMed ID: 15093908 [Abstract] [Full Text] [Related]
15. Can the apparent diffusion coefficient be used as a noninvasive parameter to distinguish tumor tissue from peritumoral tissue in cerebral gliomas? Pauleit D, Langen KJ, Floeth F, Hautzel H, Riemenschneider MJ, Reifenberger G, Shah NJ, Müller HW. J Magn Reson Imaging; 2004 Nov 01; 20(5):758-64. PubMed ID: 15503327 [Abstract] [Full Text] [Related]
16. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas. Young R, Babb J, Law M, Pollack E, Johnson G. J Magn Reson Imaging; 2007 Oct 01; 26(4):1053-63. PubMed ID: 17896374 [Abstract] [Full Text] [Related]
17. In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imaging. De Stefano N, Caramanos Z, Preul MC, Francis G, Antel JP, Arnold DL. Ann Neurol; 1998 Aug 01; 44(2):273-8. PubMed ID: 9708554 [Abstract] [Full Text] [Related]
18. [MR imaging of intracranial tumors by superconducting system operating at 0.35 tesla]. Ochiai C. No To Shinkei; 1985 May 01; 37(5):445-57. PubMed ID: 2992555 [No Abstract] [Full Text] [Related]